Downregulated miR-33b is a novel predictor associated with disease progression and poor prognosis in multiple myeloma | |
Li, Fei; Hao, Mu; Feng, Xiaoyan; Zang, Meirong; Qin, Yu; Yi, Shuhua; Li, Zengjun; Xu, Yan; Zhou, Lili; Sui, Weiwei | |
2015 | |
卷号 | 39期号:7页码:793-799 |
关键词 | Multiple myeloma miR-33b Prognosis |
ISSN号 | 0145-2126 |
DOI | 10.1016/j.leukres.2015.04.010 |
URL标识 | 查看原文 |
收录类别 | SCIE ; PUBMED |
内容类型 | 期刊论文 |
URI标识 | http://www.corc.org.cn/handle/1471x/6662605 |
专题 | 中国医学科学院 北京协和医学院 |
推荐引用方式 GB/T 7714 | Li, Fei,Hao, Mu,Feng, Xiaoyan,et al. Downregulated miR-33b is a novel predictor associated with disease progression and poor prognosis in multiple myeloma[J],2015,39(7):793-799. |
APA | Li, Fei.,Hao, Mu.,Feng, Xiaoyan.,Zang, Meirong.,Qin, Yu.,...&Qiu, Lugui.(2015).Downregulated miR-33b is a novel predictor associated with disease progression and poor prognosis in multiple myeloma.,39(7),793-799. |
MLA | Li, Fei,et al."Downregulated miR-33b is a novel predictor associated with disease progression and poor prognosis in multiple myeloma".39.7(2015):793-799. |
个性服务 |
查看访问统计 |
相关权益政策 |
暂无数据 |
收藏/分享 |
除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。
修改评论